ITEM 8.01 Other Events.
On January 7, 2022, Intra-Cellular Therapies, Inc. (the "Company") issued a
press release (the "Closing Press Release") announcing that it had closed its
previously announced public offering of 9,523,810 shares of its common stock at
a public offering price of $42.00 per share. The Company sold an aggregate of
10,952,381 shares of its common stock, including 1,428,571 additional shares
which the underwriters exercised their option in full to purchase, with net
proceeds to the Company of approximately $433.7 million, after deducting
underwriting discounts and commissions and estimated offering expenses.
The Company's Closing Press Release is filed as Exhibit 99.1 to this Current
Report and is incorporated herein by reference.
ITEM 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
99.1 Press Release of Intra-Cellular Therapies, Inc., dated January 7,
2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses